Dr. Vijayashree Murthy (Viju Murthy)

   MBBS, MS, DNB, MCh (Surgical Oncology), MD (USA)

Book An Appointment

Home / Doctors / Dr. Vijayashree Murthy (Viju Murthy)

Dr. Vijayashree Murthy (Viju Murthy)

Consultant – Breast Surgical Oncology


MBBS, MS, DNB, MCh (Surgical Oncology), MD (USA)


Breast Surgical Oncology


HCG Cancer Centre - Borivali


  • Dr. Viju Murthy is a seasoned breast surgical oncologist with an excellent academic background and high ethical standards. She has over {no. of years} years of experience in the field of breast oncology.
  • Her expertise lies in the surgical management of benign and malignant breast diseases and breast cancer screening.
  • She has a particular interest in breast conservation surgery, axillary surgery with minimum morbidity, breast reconstruction, preventative surgery for hereditary breast and ovarian cancers, and breast cancer genetics.
  • Dr. Viju firmly believes in a personalised treatment approach and therefore takes extra time to go through each case thoroughly and devise treatment plans that will have a positive impact on the treatment response, clinical outcome, and the patient’s quality of life.
Training and Certifications
  • Dr. Viju holds an esteemed NIH T32 Breast Oncology Fellowship from Roswell Park Comprehensive Cancer Centre, New York, demonstrating her commitment to cutting-edge research and advancements in the field.
  • She has completed her SSO Breast Surgical Oncology Fellowship at Maimonides Medical Centre, New York, further honing her skills in surgical management.
  • Dr. Viju's extensive training also includes a comprehensive Breast Fellowship at Tata Memorial Hospital in India, solidifying her expertise in the field.
  • Okano I, Rosenberg+I3:I25 A, Dworkin M, Murthy V, Jayaraman S, Takabe K. Direct and indirect health effects of the nuclear power plant disasters: a review for health care professionals. Int J Surg:Global Health. 2022 Sep; 5(5): pe71.
  • Tokumaru Y, Oshi M, Murthy V, Tian W, Yan L, Angarita FA, Nagahashi M, Matsuhashi N, Futamura M, Yoshida K, Miyoshi Y, Takabe K. Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC). Am J Cancer Res. 2021 Nov 15;11(11):5743-5755.
  • Gandhi S, Oshi M, Murthy V, Repasky EA, Takabe K. Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment. Cancers (Basel) 2021 May 23;13(11):2559.
  • "Murthy V, Young J, Tokumaru Y, Quinn M, Edge SB, Takabe K. Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer. Cancers (Basel). 2021 Aug 19;13(16):4167."
  • Murthy V, Oshi M, Tokumaru Y, Endo I, Takabe K. Increased apoptosis is associated with robust immune cell infiltration and cytolytic activity in breast cancer. Am J Cancer Res. 2021 Jul 15;11(7):3674-3687.
  • Oshi M, Murthy V, Takahashi H, Huyser M, Okano M, Tokumaru Y, Rashid OM, Matsuyama R, Endo I, Takabe K. Urine as a Source of Liquid Biopsy for Cancer. Cancers (Basel). 2021 May 28;13(11):2652.
  • Copeland J, Oyedeji A, Powell N, Cherian CJ, Tokumaru Y, Murthy V, Takabe K, Young J. Breast Cancer in Jamaica: Stage, Grade and Molecular Subtype Distributions Across Age Blocks, the Implications for Screening and Treatment. World J Oncol. 2021 Aug;12(4):93-103.
  • Oshi M, Newman S, Murthy V, Tokumaru Y, Yan L, Matsuyama R, Endo I, Takabe K. ITPKC as a prognostic and predictive biomarker of neoadjuvant chemotherapy for triple negative breast cancer. Cancers (Basel) 2020 Sep 25; 12(10): 2758
  • Cowan RA, Tseng J, Ali N, Dearie H, Murthy V, Gennarelli RL,  Lasonos A, Abu-Rustum N, Chi DS,  Long Roche KC, Brown CL. Exploring the Impact of Income and Race on Survival for Women with Advanced Ovarian Cancer undergoing Primary Debulking Surgery at a High-Volume Center. Gynecol Oncol. 2018 Apr;149(1):43-48.
  • Cowan RA, Tseng J, Murthy V, Srivastava R, Long Roche KC, Zivanovic O, Gardner GJ, Chi DS, Park BJ, Sonoda Y. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Gynecol Oncol. 2017 Nov; 147(2):262-266.
  • Murthy V, Pawar S, Chamberlain RS. Disease Severity, Presentation and Clinical Outcomes among Adolescents with malignant breast neoplasms: A 20-year Population-based Outcomes Study from the SEER Database (1973-2009). Clin Breast Cancer. 2017 Aug;17(5):392-398.
  • Sparber LS, Murthy V, Patil S, Ballehaninna U, Chamberlain RS. The impact of ethnicity on the incidence, tumor characteristics and treatment of Ductal Carcinoma in situ –An 11year clinical experience at a high volume teaching hospital. Surgical Science Aug 2016; 7: 348-356.
  • Bender B, Murthy V, Chamberlain RS. The changing management of chylothorax in the modern era. Eur J Cardiothoracic Surg Jan 2016; 49 (1):18-24.
  • Murthy V, Nobre PS, Sparber LS, Schaefer S, Santoro EJ, McDermott JH, Chamberlain RS, Blackwood MM. Multidisciplinary Breast Conference improves patient management and treatment. Surgical Science July 2014; 5(7): 314-319.
  • Swergold N, Murthy V, Chamberlain RS. Males at high risk for breast cancer: Who are they and how should we screen them? Surgical Science July 2014; 5(7): 320-331.
  • Kattepur AK, Patil D, Srinivas KG, Swamy S, Murthy V, Amarendra S, Gopinath KS. Adenoid cystic carcinoma of trachea masquerading as papillary thyroid cancer- a case report. Case reports in Clin Path Apr 2014; 1(2): 53-58.
  • Murthy V, Chamberlain RS. Prophylactic Mastectomy in high risk patients: Is there a role for Sentinel Lymph Node Biopsy? Clin Breast Cancer. 2013 Jun; 13(3):180-7.
  • Murthy V, Chamberlain RS. Nipple Sparing Mastectomy in modern breast care. Clin Anat. 2013 Jan; 26(1):56-65.
  • Narayan P, Murthy V, Su M, Grossman R, Chamberlain RS. Primary Myeloid sarcoma masquerading as a duodenal mass. Case Report Hematol. 2012; 2012: 490438.
  • Murthy V, Ballehaninna UK, Chamberlain RS. Unanswered questions about the role of axillary dissection in women with invasive breast cancer and sentinel node metastasis. Clin Breast Cancer 2012 Oct; 12(5):305-307.
  • Murthy V, Chamberlain RS. Menopausal Symptoms in Young Survivors of Breast Cancer:  A growing problem without an ideal solution. J Moffitt Cancer Center: Cancer Control 2012 Oct; 19(4): 317-329.
  • Murthy V, Gopinath KS. Reconstruction of groin defects following radical inguinal lymphadenectomy: an evidence-based review. Indian J Surg Oncol 2012 June; 3(2): 130-138.
  • Murthy V, Gopinath KS, Anand K. Case Report: Skin Sparing Mastectomy in LABC – A Possibility? Surgical Science 2012 April; 3(4): 226-231.
  • Murthy V, Chamberlain RS. Defining a place for Nipple Sparing Mastectomy in modern breast care: an evidence-based review. Breast J Nov-Dec 2013; 19(6): 571-81.
  • Murthy V, Chamberlain RS. Recommendation to revise the AJCC/UICC Breast Cancer Staging System for inclusion of proven prognostic factors: ER/PR receptor status and HER 2 neu. Clin Breast Cancer 2011 Oct; 11(5): 346-7.
  • Murthy V, Chamberlain RS. Further expansion of the AJCC/UICC Breast Cancer Staging system to encompass unique problems in the developing world. Ann Surg Oncol. 2011 Dec; 18 Suppl 3:S278-80.
  • Murthy V, Gopinath. Perspectives of tumor markers in gastrointestinal malignancies. An overview. Indian J Surg 2008 Dec; 70(6):274-80.
  • Manjunath S, Ramachandra C, Murthy V, Murthy PS, Prabhakaran PS, Attili VSS. Surgical resection for locally invasive renal cell carcinoma is it worthwhile? Indian J Urol, 2007 July; 23(3):246-9.
  • Book Chapter -
  • Chamberlain RS, Murthy V, Sparber LS, Sridharan P. Perioperative care of the surgical patient.
  • In: Slonim AD, Levitov AB, Marik P, eds. Point of Care Medicine. New York, NY: McGraw-Hill; 2013. Pg 467-504.

   Practices at

Other Doctors